Publication | Closed Access

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Aflibercept Versus PlaceboUrologyOncologyMedicineClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseasePharmacologyPhase 3